NATIONAL ASSOCIATION OF NUCLEAR PHARMACIES

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2012–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	4	1
2024	—	4	1
2023	—	4	1
2022	—	4	1
2021	—	6	1
2020	—	7	1
2019	—	4	1
2018	—	4	2
2017	—	4	1
2016	—	4	1
2015	—	4	1
2014	—	4	1
2013	—	4	1
2012	—	4	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
CROWELL & MORING LLP	—	25
BOSE PUBLIC AFFAIRS GROUP	—	39

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	52
SENATE	51
Natl Institutes of Health (NIH)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	49
Medicare/Medicaid	Medicare/Medicaid	20

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 4317119th Congress

PBM Reform Act of 2025

2025 · third_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

S. 297; HR 4317

Client expense: — · Firm income: —

Matched citations: HR 4317

S. 297119th Congress

PSA Screening for HIM Act

2025 · third_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

S. 297; HR 4317

Client expense: — · Firm income: —

Matched citations: S. 297

H.R. 1199118th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2023

2024 · second_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023 (H.R. 1199/S 1544), All Provisions

Client expense: — · Firm income: —

Matched citations: H.R. 1199

S. 1544118th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2023

2024 · second_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023 (H.R. 1199/S 1544), All Provisions

Client expense: — · Firm income: —

Matched citations: S 1544

Show 21 more cited filings

H.R. 1199118th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2023

2023 · third_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023 (H.R. 1199), All Provisions

Client expense: — · Firm income: —

Matched citations: H.R. 1199

H.R. 1199118th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2023

2023 · second_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023 (H.R. 1199), All Provisions

Client expense: — · Firm income: —

Matched citations: H.R. 1199

H.R. 1199118th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2023

2023 · first_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023 (H.R. 1199), All Provisions

Client expense: — · Firm income: —

Matched citations: H.R. 1199

H.R. 4479117th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2021

2022 · fourth_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (S. 2609, H.R. 4479), All Provisions

Client expense: — · Firm income: —

Matched citations: H.R. 4479

S. 2609117th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2021

2022 · fourth_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (S. 2609, H.R. 4479), All Provisions

Client expense: — · Firm income: —

Matched citations: S. 2609

H.R. 4479117th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2021

2022 · third_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (S. 2609, H.R. 4479), All Provisions

Client expense: — · Firm income: —

Matched citations: H.R. 4479

S. 2609117th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2021

2022 · third_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (S. 2609, H.R. 4479), All Provisions

Client expense: — · Firm income: —

Matched citations: S. 2609

H.R. 4479117th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2021

2022 · second_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (S. 2609, H.R. 4479), All Provisions

Client expense: — · Firm income: —

Matched citations: H.R. 4479

S. 2609117th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2021

2022 · second_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (S. 2609, H.R. 4479), All Provisions

Client expense: — · Firm income: —

Matched citations: S. 2609

H.R. 4479117th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2021

2022 · first_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to nuclear pharmaceutical reinbursement S.2609/H.R. 4479, FIND Act, all provisions

Client expense: — · Firm income: —

Matched citations: H.R. 4479

S. 2609117th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2021

2022 · first_quarter · Firm: BOSE PUBLIC AFFAIRS GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to nuclear pharmaceutical reinbursement S.2609/H.R. 4479, FIND Act, all provisions

Client expense: — · Firm income: —

Matched citations: S.2609

S. 959113th Congress

Pharmaceutical Quality, Security, and Accountability Act

2016 · fourth_quarter · Firm: CROWELL & MORING LLP

Open original LDA filing ↗

Cited source text and reported amounts

The Senate Health, Education, Labor, & Pensions (HELP) Committee Pharmaceutical Compounding Quality and Accountability Act (S. 959), the House Energy and Commerce Committee Compounding Pharmacies, and the Pharmaceutical Quality, Security and Accountability Act (S.959).

Client expense: — · Firm income: $10,000

Matched citations: S.959

S. 959114th Congress

Apprenticeship and Jobs Training Act of 2015

2016 · fourth_quarter · Firm: CROWELL & MORING LLP

Open original LDA filing ↗

Cited source text and reported amounts

The Senate Health, Education, Labor, & Pensions (HELP) Committee Pharmaceutical Compounding Quality and Accountability Act (S. 959), the House Energy and Commerce Committee Compounding Pharmacies, and the Pharmaceutical Quality, Security and Accountability Act (S.959).

Client expense: — · Firm income: $10,000

Matched citations: S. 959

S. 959113th Congress

Pharmaceutical Quality, Security, and Accountability Act

2016 · third_quarter · Firm: CROWELL & MORING LLP

Open original LDA filing ↗

Cited source text and reported amounts

The Senate Health, Education, Labor, & Pensions (HELP) Committee Pharmaceutical Compounding Quality and Accountability Act (S. 959), the House Energy and Commerce Committee Compounding Pharmacies, and the Pharmaceutical Quality, Security and Accountability Act (S.959).

Client expense: — · Firm income: $5,000

Matched citations: S.959

S. 959114th Congress

Apprenticeship and Jobs Training Act of 2015

2016 · third_quarter · Firm: CROWELL & MORING LLP

Open original LDA filing ↗

Cited source text and reported amounts

The Senate Health, Education, Labor, & Pensions (HELP) Committee Pharmaceutical Compounding Quality and Accountability Act (S. 959), the House Energy and Commerce Committee Compounding Pharmacies, and the Pharmaceutical Quality, Security and Accountability Act (S.959).

Client expense: — · Firm income: $5,000

Matched citations: S. 959

S. 959113th Congress

Pharmaceutical Quality, Security, and Accountability Act

2016 · second_quarter · Firm: CROWELL & MORING LLP

Open original LDA filing ↗

Cited source text and reported amounts

The Senate Health, Education, Labor, & Pensions (HELP) Committee Pharmaceutical Compounding Quality and Accountability Act (S. 959), the House Energy and Commerce Committee Compounding Pharmacies, and the Pharmaceutical Quality, Security and Accountability Act (S.959).

Client expense: — · Firm income: $5,000

Matched citations: S.959

S. 959114th Congress

Apprenticeship and Jobs Training Act of 2015

2016 · second_quarter · Firm: CROWELL & MORING LLP

Open original LDA filing ↗

Cited source text and reported amounts

The Senate Health, Education, Labor, & Pensions (HELP) Committee Pharmaceutical Compounding Quality and Accountability Act (S. 959), the House Energy and Commerce Committee Compounding Pharmacies, and the Pharmaceutical Quality, Security and Accountability Act (S.959).

Client expense: — · Firm income: $5,000

Matched citations: S. 959

S. 959113th Congress

Pharmaceutical Quality, Security, and Accountability Act

2016 · first_quarter · Firm: CROWELL & MORING LLP

Open original LDA filing ↗

Cited source text and reported amounts

The Senate Health, Education, Labor, & Pensions (HELP) Committee Pharmaceutical Compounding Quality and Accountability Act (S. 959), the House Energy and Commerce Committee Compounding Pharmacies, and the Pharmaceutical Quality, Security and Accountability Act (S.959).

Client expense: — · Firm income: $5,000

Matched citations: S.959

S. 959114th Congress

Apprenticeship and Jobs Training Act of 2015

2016 · first_quarter · Firm: CROWELL & MORING LLP

Open original LDA filing ↗

Cited source text and reported amounts

The Senate Health, Education, Labor, & Pensions (HELP) Committee Pharmaceutical Compounding Quality and Accountability Act (S. 959), the House Energy and Commerce Committee Compounding Pharmacies, and the Pharmaceutical Quality, Security and Accountability Act (S.959).

Client expense: — · Firm income: $5,000

Matched citations: S. 959

S. 959113th Congress

Pharmaceutical Quality, Security, and Accountability Act

2015 · fourth_quarter · Firm: CROWELL & MORING LLP

Open original LDA filing ↗

Cited source text and reported amounts

The Senate Health, Education, Labor, & Pensions (HELP) Committee Pharmaceutical Compounding Quality and Accountability Act (S. 959), the House Energy and Commerce Committee Compounding Pharmacies, and the Pharmaceutical Quality, Security and Accountability Act (S.959).

Client expense: — · Firm income: $5,000

Matched citations: S.959

S. 959114th Congress

Apprenticeship and Jobs Training Act of 2015

2015 · fourth_quarter · Firm: CROWELL & MORING LLP

Open original LDA filing ↗

Cited source text and reported amounts

The Senate Health, Education, Labor, & Pensions (HELP) Committee Pharmaceutical Compounding Quality and Accountability Act (S. 959), the House Energy and Commerce Committee Compounding Pharmacies, and the Pharmaceutical Quality, Security and Accountability Act (S.959).

Client expense: — · Firm income: $5,000

Matched citations: S. 959

Source: Senate LDA

NATIONAL ASSOCIATION OF NUCLEAR PHARMACIES — Lobbying Disclosure | Poliscope